The EULAR updated their recommendations for antirheumatic drug use among patients with RMDs during pregnancy and fertility ...

HHS announced that recommending COVID-19 vaccinations for healthy children and pregnant women would no longer be routine, ...

The median time to treatment initiation is increasing across cancer types, and this appears to be driven by an increase in stage I cancer diagnoses, data suggest.

Waist-to-height ratio had a better predictive value than BMI in assessing liver fibrosis and steatosis outcomes across ages and racial groups.

For adults with diabetes and obesity, GLP-1 RAs are associated with a reduced risk for obesity-related cancer compared with DPP-4 inhibitors.

Compounded vs non-compounded GLP-1 RA drug products are associated with an increased risk for adverse events such as nausea and diarrhea.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

AACE released clinical guidelines on the diagnosis, management, and surveillance of tumors related to multiple endocrine ...

Early-life risk factors including lack of breastfeeding and low birth weight were associated with increased risk for adult-onset type 2 diabetes.